NORMALIZATION METHOD OF ERYTHROCYTES CATALASE ACTIVITY OF NEWBORN CALVES WITH IRON DEFICIENCY Russian patent published in 2017 - IPC A61K31/205 A61K31/295 A61K35/50 A61P7/06 

FIELD: veterinary medicine.

SUBSTANCE: to correct the erythrocytes catalase activity of newborn calves with iron deficiency it is assigned Ferroglucinum 150 mg (2 ml) intramuscularly, twice with the interval of 4 days, Krezacin 5 mg/kg per day, beginning simultaneously with the first injection of Ferroglucinum, including it in the feeding scheme for 4 days, and Gamavit intramuscularly once a day in the morning 0.05 ml/kg for 4 days, beginning simultaneously with Ferroglucinum and Krezacin.

EFFECT: use of the claimed method for correcting the erythrocytes catalase activity of newborn calves with iron deficiency in biology and veterinary medicine will help to avoid many vascular complications and optimize the microcirculation and trophism of animals tissues, to improve the livestock health, to reduce mortality, to accelerate the growth and development of calves, to increase the weight gain.

1 tbl, 1 dwg, 2 ex